Implementing and Using an ELN in a Validated Environment at AstraZeneca
AstraZeneca wanted to improve efficiency of validated workflows in GMP API manufacturing by deploying an electronic lab notebook (ELN). One of their primary challenges in implementing the ELN was getting buy-in from the myriad stakeholders who interact with the experimental data being recorded. This Case Study describes how AstraZeneca achieved this buy-in and how their ELN deployment has eliminated paper-based workflows, improved overall quality assurance and compliance and resulted in greater than 50% time savings in documentation.
Please complete the form to request the Case Study.
BIOVIA Workbook at AstraZeneca